Renew Biopharma has a total of 53 patents globally, out of which 23 have been granted. Of these 53 patents, 16% patents are active. The United States of America is where Renew Biopharma has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the United States of America seems to be the main focused R&D centre and is the origin country of Renew Biopharma.
Renew Biopharma was founded in 2017. Renew Biopharma is a San Diego based biotech startup developing novel therapeutic molecules through synthetic biology and enzyme engineering. The company focuses on treatments for neuroinflammation, chronic pain, traumatic brain injury, and neurodegenerative diseases. Its proprietary technologies enable the design of innovative compounds that can effectively cross the blood–brain barrier.
Do read about some of the most popular patents of Renew Biopharma which have been covered by us in this article and also you can find Renew Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Renew Biopharma patent portfolio.
How many patents does Renew Biopharma have?
Renew Biopharma has a total of 53 patents globally. These patents belong to 24 unique patent families. Out of 53 patents, 9 patents are active.
How Many Patents did Renew Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Renew Biopharma Applications Filed | Renew Biopharma Patents Granted |
| 2024 | – | 1 |
| 2022 | 1 | – |
| 2021 | – | 1 |
| 2020 | 10 | – |
| 2019 | 6 | – |
| 2018 | 3 | – |
| 2017 | 7 | 1 |
| 2016 | 2 | 3 |
| 2015 | 1 | 8 |
| 2014 | – | 3 |
How many Renew Biopharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Renew Biopharma File in Different Countries?
Countries in which Renew Biopharma Filed Patents
| Country | Patents |
| United States of America | 29 |
| Australia | 9 |
| Canada | 5 |
| Israel | 2 |
| Europe (EPO) | 1 |
Where are Research Centers of Renew Biopharma Patents Located?
The Research Centre for all the Renew Biopharma patents is the United States of America.
Best Renew Biopharma Patents
WO2019183152A1 is the most popular patent in the Renew Biopharma portfolio. It has received 23 citations so far from companies like Ginkgo Bioworks, Invizyne Technologies etc.
Below is the list of most cited patents of Renew Biopharma:
| Publication Number | Citation Count |
| WO2019183152A1 | 23 |
| US8075641B2 | 20 |
| US20210238561A1 | 9 |
| US9428779B2 | 7 |
| US8969066B2 | 7 |
| US8268553B2 | 6 |
| US20220364066A1 | 5 |
| WO2021067748A1 | 5 |
| WO2021081246A1 | 4 |
| US8987433B2 | 4 |
What Percentage of Renew Biopharma US Patent Applications were Granted?
Renew Biopharma (Excluding its subsidiaries) has filed 29 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 19 has been granted leading to a grant rate of 70%.
Below are the key stats of Renew Biopharma patent prosecution at the USPTO.
Which Law Firms are Managing US Patents for Renew Biopharma?
| Law Firm | Total Applications | Success Rate |
| Procopio Renew Biopharma | 15 | 73.33% |
| Arnold & Porter Kaye Scholer Llp | 5 | 100.0% |
| Wilson Sonsini Goodrich & Rosati | 4 | 33.33% |
| Cooley Llp | 3 | 50.0% |
| The Scripps Research Institute | 2 | 50.0% |
What are Renew Biopharma key innovation segments?
What Technologies are Covered by Renew Biopharma?
The chart below distributes patents filed by Renew Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Renew Biopharma thinks it’s important to protect particular technological inventions.
R&D Focus: How has Renew Biopharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Renew Biopharma?
